Terms: = Endocrine gland cancer AND CIITA, P33076, 4261, ENSG00000179583, MHC2TA, C2TA
22 results:
1. A protein-based prognostic model for pancreatic ductal adenocarcinoma: Construction and validation.
Xu Y; Wang Y; Chen Q; Yao T; Qiu J; Ni L; Chen H; Liang T
Pancreatology; 2023 Dec; 23(8):1003-1013. PubMed ID: 37923686
[TBL] [Abstract] [Full Text] [Related]
2. Tumor cells fail to present MHC-II-restricted epitopes derived from oncogenes to CD4+ T cells.
Brightman SE; Naradikian MS; Thota RR; Becker A; Montero L; Bahmanof M; Premlal ALR; Greenbaum JA; Peters B; Cohen EE; Miller AM; Schoenberger SP
JCI Insight; 2023 Jan; 8(2):. PubMed ID: 36512410
[TBL] [Abstract] [Full Text] [Related]
3. Risk-stratified papillary thyroid microcarcinoma: post-operative management and treatment outcome in a single center.
Kanokwongnuwat W; Larbcharoensub N; Sriphrapradang C; Suppasilp C; Thamnirat K; Sakulpisuti C; Kositwattanarerk A; Utamakul C; Sritara C; Chamroonrat W
Endocrine; 2022 Jun; 77(1):134-142. PubMed ID: 35476179
[TBL] [Abstract] [Full Text] [Related]
4. Efficacy of EUS-guided FNB using a Franseen needle for tissue acquisition and microsatellite instability evaluation in unresectable pancreatic lesions.
Sugimoto M; Irie H; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Nakamura J; Takasumi M; Hashimoto M; Kato T; Kobashi R; Kobayashi Y; Hashimoto Y; Hikichi T; Ohira H
BMC Cancer; 2020 Nov; 20(1):1094. PubMed ID: 33176750
[TBL] [Abstract] [Full Text] [Related]
5. Increased Overall Mortality Even after Risk Reducing Surgery for
Öfverholm A; Einbeigi Z; Wigermo A; Holmberg E; Karsson P
Genes (Basel); 2019 Dec; 10(12):. PubMed ID: 31888263
[TBL] [Abstract] [Full Text] [Related]
6. The RNA m6A methyltransferase METTL3 promotes pancreatic cancer cell proliferation and invasion.
Xia T; Wu X; Cao M; Zhang P; Shi G; Zhang J; Lu Z; Wu P; Cai B; Miao Y; Jiang K
Pathol Res Pract; 2019 Nov; 215(11):152666. PubMed ID: 31606241
[TBL] [Abstract] [Full Text] [Related]
7. Survival disparities among racial/ethnic groups of women with ovarian cancer: An update on data from the Surveillance, Epidemiology and End Results (SEER) registry.
Stenzel AE; Buas MF; Moysich KB
Cancer Epidemiol; 2019 Oct; 62():101580. PubMed ID: 31400533
[TBL] [Abstract] [Full Text] [Related]
8. The antitumor effects of entinostat in ovarian cancer require adaptive immunity.
Smith HJ; McCaw TR; Londono AI; Katre AA; Meza-Perez S; Yang ES; Forero A; Buchsbaum DJ; Randall TD; Straughn JM; Norian LA; Arend RC
Cancer; 2018 Dec; 124(24):4657-4666. PubMed ID: 30423192
[TBL] [Abstract] [Full Text] [Related]
9. The pathobiology of primary testicular diffuse large B-cell lymphoma: Implications for novel therapies.
Twa DDW; Mottok A; Savage KJ; Steidl C
Blood Rev; 2018 May; 32(3):249-255. PubMed ID: 29289361
[TBL] [Abstract] [Full Text] [Related]
10. Epigenetic modifiers upregulate MHC II and impede ovarian cancer tumor growth.
Turner TB; Meza-Perez S; Londoño A; Katre A; Peabody JE; Smith HJ; Forero A; Norian LA; Straughn JM; Buchsbaum DJ; Randall TD; Arend RC
Oncotarget; 2017 Jul; 8(27):44159-44170. PubMed ID: 28498806
[TBL] [Abstract] [Full Text] [Related]
11. Identification of Novel Oncogenic Mutations in Thyroid cancer.
Pitt SC; Hernandez RA; Nehs MA; Gawande AA; Moore FD; Ruan DT; Cho NL
J Am Coll Surg; 2016 Jun; 222(6):1036-1043.e2. PubMed ID: 27010584
[TBL] [Abstract] [Full Text] [Related]
12. Exome sequencing of bilateral testicular germ cell tumors suggests independent development lineages.
Brabrand S; Johannessen B; Axcrona U; Kraggerud SM; Berg KG; Bakken AC; Bruun J; Fosså SD; Lothe RA; Lehne G; Skotheim RI
Neoplasia; 2015 Feb; 17(2):167-74. PubMed ID: 25748235
[TBL] [Abstract] [Full Text] [Related]
13. Recurrent genomic rearrangements in primary testicular lymphoma.
Twa DD; Mottok A; Chan FC; Ben-Neriah S; Woolcock BW; Tan KL; Mungall AJ; McDonald H; Zhao Y; Lim RS; Nelson BH; Milne K; Shah SP; Morin RD; Marra MA; Scott DW; Gascoyne RD; Steidl C
J Pathol; 2015 Jun; 236(2):136-41. PubMed ID: 25712539
[TBL] [Abstract] [Full Text] [Related]
14. Research on the epigenetic modification of pancreatic cancer vaccine.
Cao W; Zhou G; Qiu J; Xu L; Ding X; Zhang H; Zhou X
Hepatogastroenterology; 2014; 61(130):272-7. PubMed ID: 24901123
[TBL] [Abstract] [Full Text] [Related]
15. Epigenetically modified pancreatic carcinoma PANC-1 cells can act as cancer vaccine to enhance antitumor immune response in mice.
Tao Y; Lin F; Li T; Xie J; Shen C; Zhu Z
Oncol Res; 2013; 21(6):307-16. PubMed ID: 25198660
[TBL] [Abstract] [Full Text] [Related]
16. First signature of islet beta-cell-derived naturally processed peptides selected by diabetogenic class II MHC molecules.
Suri A; Walters JJ; Rohrs HW; Gross ML; Unanue ER
J Immunol; 2008 Mar; 180(6):3849-56. PubMed ID: 18322192
[TBL] [Abstract] [Full Text] [Related]
17. Overexpression of gastrin-releasing peptide receptors in tumor-associated blood vessels of human ovarian neoplasms.
Fleischmann A; Waser B; Reubi JC
Cell Oncol; 2007; 29(5):421-33. PubMed ID: 17726264
[TBL] [Abstract] [Full Text] [Related]
18. [Study of HLA molecules and its associated genes expression in human ovarian cancer cells].
Ge HL; Zhang XR; Wang Y; Ma AL; Zhang HZ; Wang SJ; Zhou GY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jan; 19(1):41-4. PubMed ID: 15132903
[TBL] [Abstract] [Full Text] [Related]
19. Transfection of dendritic cells (DCs) with the ciita gene: increase in immunostimulatory activity of DCs.
Märten A; Ziske C; Schöttker B; Weineck S; Renoth S; Buttgereit P; Schakowski F; König S; von Rücker A; Allera A; Schroers R; Sauerbruch T; Wittig B; Schmidt-Wolf IG
Cancer Gene Ther; 2001 Mar; 8(3):211-9. PubMed ID: 11332992
[TBL] [Abstract] [Full Text] [Related]
20. Interferon regulatory factor-2 point mutations in human pancreatic tumors.
Xi H; Blanck G
Int J Cancer; 2000 Sep; 87(6):803-8. PubMed ID: 10956389
[TBL] [Abstract] [Full Text] [Related]
[Next]